These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 12039409

  • 1. Frequency of functional interleukin-10 promoter polymorphism is different between relapse-onset and primary progressive multiple sclerosis.
    de Jong BA, Westendorp RG, Eskdale J, Uitdehaag BM, Huizinga TW.
    Hum Immunol; 2002 Apr; 63(4):281-5. PubMed ID: 12039409
    [Abstract] [Full Text] [Related]

  • 2. Interleukin-10 promoter polymorphisms in patients with multiple sclerosis.
    Myhr KM, Vågnes KS, Marøy TH, Aarseth JH, Nyland HI, Vedeler CA.
    J Neurol Sci; 2002 Oct 15; 202(1-2):93-7. PubMed ID: 12220699
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Circulating dendritic cells of multiple sclerosis patients are proinflammatory and their frequency is correlated with MS-associated genetic risk factors.
    Thewissen K, Nuyts AH, Deckx N, Van Wijmeersch B, Nagels G, D'hooghe M, Willekens B, Cras P, Eijnde BO, Goossens H, Van Tendeloo VF, Stinissen P, Berneman ZN, Hellings N, Cools N.
    Mult Scler; 2014 Apr 15; 20(5):548-57. PubMed ID: 24057429
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Evidence for additional genetic risk indicators of relapse-onset MS within the HLA region.
    de Jong BA, Huizinga TW, Zanelli E, Giphart MJ, Bollen EL, Uitdehaag BM, Polman CH, Westendorp RG.
    Neurology; 2002 Aug 27; 59(4):549-55. PubMed ID: 12196647
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Decreased frequency of the tumor necrosis factor alpha -308 allele in Serbian patients with multiple sclerosis.
    Drulović J, Popadić D, Mesaros S, Dujmović I, Cvetković I, Miljković D, Stojsavljević N, Pravica V, Pekmezović T, Bogdanović G, Jarebinski M, Mostarica Stojković M.
    Eur Neurol; 2003 Aug 27; 50(1):25-9. PubMed ID: 12824709
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.